| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |